Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

NCT02432807 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Conjunctivitis

Interventions

DRUG: Vancomycin 1.1%
DRUG: Placebo

Sponsor

Kurobe LLC